Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening

被引：0
作者：
David C Wheeler
Konrad M Szymanski
Amanda Black
David E Nelson
机构：
[1] National Cancer Institute,Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics
[2] McGill University Health Centre,Division of Urology
[3] National Cancer Institute,Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics
[4] National Cancer Institute,Cancer Prevention Fellowship Program Branch, Center for Cancer Training
来源：
BMC Cancer | / 11卷
关键词：
Prostate Cancer; Prostate Specific Antigen; Share Decision Making; Default Option; Prostate Cancer Screening;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 169 条
[1]  
Andriole G(2009)Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 1310-1319
[2]  
Crawford E(2009)Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 1320-1328
[3]  
Grubb R(2010)Mortality results from the Goteborg randomized population-based prostate-cancer screening trial Lancet Oncol 11 725-732
[4]  
Buys S(2009)Screening for prostate cancer remains controversial BMJ 339 784-786
[5]  
Chia D(2008)Screening for prostate cancer. U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med 149 185-191
[6]  
Church T(2010)American Cancer Society guideline for the early detection of prostate cancer CA Cancer J Clin 60 70-98
[7]  
Schröder F(1996)Shared decision making in the real world J Gen Intern Med 11 377-378
[8]  
Hugosson J(1997)Shared decision making and the future of managed care Disease Management and Clinical Outcomes 1 15-16
[9]  
Roobol M(2000)Decision-aids for prostate cancer screening J Fam Pract 49 425-427
[10]  
Tammela T(1997)A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia Disease Management and Clinical Outcomes 1 5-14
12345678910